Global X Genomics & Biotechnology ETFGlobal X Genomics & Biotechnology ETFGlobal X Genomics & Biotechnology ETF

Global X Genomics & Biotechnology ETF

Inga transaktioner
Se i superdiagram

Nyckeltal

Assets under management (AUM)
‪95.36 M‬USD
Fund flows (1Y)
‪−59.31 M‬USD
Dividend yield (indicated)
Discount/Premium to NAV
−1.06%

Om Global X Genomics & Biotechnology ETF

Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Global X
Expense ratio
0.50%
Inception date
5 apr. 2019
Index tracked
Solactive Genomics Index
Management style
Passive

Classification

Asset Class
Equity
Kategori
Sektor
Focus
Theme
Niche
Framsteg inom genomiken
Strategi
Vanilj
Weighting scheme
Börsvärde
Selection criteria
Börsvärde

Returns

1 månad3 månaderHittills i år1 år3 år5 år
Price performance
NAV total return

What's in the fund

As of 7 maj 2024
Exposure type
AktierBonds, Cash & Other
Hälsoteknik
Aktier99.97%
Hälsoteknik99.16%
Hälsotjänster0.78%
Bonds, Cash & Other0.03%
Diverse0.05%
Likvida medel−0.02%
Stock breakdown by region
97%2%
Nordamerika97.31%
Asien2.69%
Latinamerika0.00%
Europa0.00%
Afrika0.00%
Mellanöstern0.00%
Oceanien0.00%
Top 10 holdings

Utdelningar

Utdelningshistorik

Assets under management (AUM)

Fund Flows